MX9300409A - Hexahidroazepinonas y tetrahidrobenzoazepinonas sustituidas. - Google Patents

Hexahidroazepinonas y tetrahidrobenzoazepinonas sustituidas.

Info

Publication number
MX9300409A
MX9300409A MX9300409A MX9300409A MX9300409A MX 9300409 A MX9300409 A MX 9300409A MX 9300409 A MX9300409 A MX 9300409A MX 9300409 A MX9300409 A MX 9300409A MX 9300409 A MX9300409 A MX 9300409A
Authority
MX
Mexico
Prior art keywords
substituted
tetrahidrobenzoazepinonas
hexahidroazepinonas
tetrahydrobenzoazepinones
haxahydroazepinones
Prior art date
Application number
MX9300409A
Other languages
English (en)
Spanish (es)
Inventor
John A Lowe Iii
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX9300409A publication Critical patent/MX9300409A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX9300409A 1992-01-27 1993-01-26 Hexahidroazepinonas y tetrahidrobenzoazepinonas sustituidas. MX9300409A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82567792A 1992-01-27 1992-01-27

Publications (1)

Publication Number Publication Date
MX9300409A true MX9300409A (es) 1993-07-01

Family

ID=25244657

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9300409A MX9300409A (es) 1992-01-27 1993-01-26 Hexahidroazepinonas y tetrahidrobenzoazepinonas sustituidas.

Country Status (19)

Country Link
EP (1) EP0625145A1 (fr)
JP (1) JPH07503465A (fr)
KR (1) KR950700257A (fr)
CN (1) CN1074903A (fr)
AU (1) AU3276193A (fr)
BR (1) BR9207071A (fr)
CA (1) CA2117367A1 (fr)
CZ (1) CZ391092A3 (fr)
FI (1) FI943513A7 (fr)
HU (1) HUT70496A (fr)
IL (1) IL104472A0 (fr)
MX (1) MX9300409A (fr)
NO (1) NO942775L (fr)
NZ (1) NZ245759A (fr)
RU (1) RU94038063A (fr)
TW (1) TW213901B (fr)
WO (1) WO1993015059A1 (fr)
YU (1) YU4393A (fr)
ZA (1) ZA93582B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2097688A1 (es) * 1993-07-14 1997-04-01 Pfizer Hexahidroazepinonas y tetrahidrobenzazepinonas sustituidas.
JP2862675B2 (ja) * 1993-07-26 1999-03-03 フアイザー・インコーポレイテツド 選択的コレシストキニン−b受容体拮抗薬としてのテトラヒドロ−1h−ベンゾアゼピノンおよびヘキサヒドロアゼピノン
JPH09505597A (ja) * 1993-11-22 1997-06-03 メルク エンド カンパニー インコーポレーテッド 3−アシルアミノベンゾアゼピン類
US5453424A (en) * 1993-11-22 1995-09-26 Merck & Co., Inc. Furanodiazepines
JP3030091B2 (ja) * 1994-10-04 2000-04-10 ファイザー・インコーポレーテッド 3−アミノ−ベンゾ[b]アゼピノンを製造するための方法および中間体
ATE210447T1 (de) * 1994-10-14 2001-12-15 Glaxo Wellcome Spa Verwendung von cck-b rezeptor antagonisten zur behandlung von schlafstörungen
DE10153348A1 (de) 2001-10-29 2003-05-08 Gruenenthal Gmbh Substituierte Benzo(b)azepin-2-on-Verbindungen
CA2612490A1 (fr) * 2005-06-16 2007-10-25 Novartis Ag Inhibiteurs de l'hc contenant du lactame

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0166357A3 (fr) * 1984-06-26 1988-10-26 Merck & Co. Inc. Benzo-lactames condensés et leurs compositions pharmaceutiques
US4767756A (en) * 1987-07-17 1988-08-30 E. R. Squibb & Sons, Inc. 3-substituted benzazepines
EP0322779A3 (fr) * 1987-12-29 1991-05-08 Yoshitomi Pharmaceutical Industries, Ltd. Composés de benzolactame et leur utilisation pharmaceutique
US5206234A (en) * 1990-10-22 1993-04-27 Merck & Co., Inc. Benzolactam analogs as antagonists of cck

Also Published As

Publication number Publication date
CA2117367A1 (fr) 1993-08-05
CZ391092A3 (en) 1994-01-19
NZ245759A (en) 1997-06-24
AU3276193A (en) 1993-09-01
FI943513A0 (fi) 1994-07-26
HU9402195D0 (en) 1994-09-28
KR950700257A (ko) 1995-01-16
NO942775L (no) 1994-09-20
NO942775D0 (no) 1994-07-26
FI943513L (fi) 1994-07-26
BR9207071A (pt) 1995-12-05
HUT70496A (en) 1995-10-30
YU4393A (sr) 1996-01-09
CN1074903A (zh) 1993-08-04
EP0625145A1 (fr) 1994-11-23
FI943513A7 (fi) 1994-07-26
RU94038063A (ru) 1996-05-27
JPH07503465A (ja) 1995-04-13
ZA93582B (en) 1994-07-27
TW213901B (fr) 1993-10-01
WO1993015059A1 (fr) 1993-08-05
IL104472A0 (en) 1993-05-13

Similar Documents

Publication Publication Date Title
ES2116594T3 (es) Ansamicinas biciclicas y su uso como agentes antitumorales.
DK20892D0 (da) Seksuelt hjaelpemiddel
MX9301634A (es) Quinuclidinas peptidicas.
LV5824B4 (lv) Cilveku psihozes arstesanas panemiens
MY111201A (en) New imidazopyridines
KR890700313A (ko) 살균 조성물
MX9205219A (es) Un material de n-oxido de tramadol, enantiomeros, y composiciones del mismo, y su uso
ES2157992T3 (es) Alcoxi-alquil-carbamatos de imidazo(1,2-a)piridinas.
FI945085L (fi) Yhdistelmä-neu-reseptoristimulaatiotekijä
FI930621A0 (fi) Bifenylsubstituerade kinolinderivat
NO903148L (no) Hemoreguleringspeptider.
FI891986A7 (fi) Farmaseuttiset koostumukset psoriasiksen hoitoon
ITMI913465A0 (it) Procedimento per la depurazione dell'1.1.1-trifluoro-2-fuoroetano
DK0417003T3 (da) Anvendelse af antiprogestomimetiske forbindelser til fremme af ovulation
DK0545582T3 (da) Forbedret fiskeproduktion
ES2012314A4 (es) Tratamiento de composiciones precursoras de poliamida.
DK87888A (da) Terapeutisk anvendelse af tindijoddeuteroporfyrin
NO982562D0 (no) Sammensetning for behandling av smerte
FI890810A7 (fi) Palovammojen käsittely
DK0967986T3 (da) Anvendelse af humant alfa1-surt glycoprotein til fremstilling af et farmaceutisk præparat
ES2167942T3 (es) Empleo de 2-aminotetralinas 6,7-sustituidas apropiadas para la preparacion de una composicion farmaceutica para el tratamiento terapeutico de patologias inflamatorias y/o autoinmunes.
FR2566265B1 (fr) Bague d'extension phallique
ITMI910967V0 (it) Regolo per la determinazione dell'intensita' del dolore
KR910009110U (ko) 방향용 양초의 구조
DK459286D0 (da) Terapeutisk komposition